Find trending articles through Social News Discovery®! Providing a collaboration of news through social media technologies.
Follow your friends and create your own Online Social Newspaper! Invite your friends to follow you from Facebook. Filter the news articles you see by section, clipper, or mood. Rate each article and comment on all news clips!
Receive site and email notifications about comments and news clips that you are collaborating on!
Get the latest news on the Everyone page, the viral and trending news clips will always be at the top! See the trending news and articles!
"The FDA’s Endocrine and Metabolic Drug Advisory Committee is scheduled to vote next week on whether the diabetes medication empagliflozin (Jardiance, Eli Lilly/Boehringer Ingelheim) reduces the risk of cardiovascular death, according to documents posted online ahead of the June 28 meeting. The advisors will discuss whether the label for empagliflozin should include a claim that it cuts the risk of heart problems in patients at high risk.", www.ptcommunity.com
"When Eli Lilly and Boehringer Ingelheim announced last year that their SGLT2 med, Jardiance, had become the first in that class of diabetes meds to show it could lower the risk of major cardiovascular events, the pharma world took notice. Now the companies will find out if the FDA will as well.", www.fiercepharma.com
Please enjoy the site during our beta phase and provide us with feedback on suggestions and issue details. Please remember that we are still in beta and there will be issues and site changes during this time.
Newsclip® the leading Online Social Newspaper, find trending articles through Social News Discovery®!
You can reopen the "Getting Started Tutorial" dialog from within the About menu in the top right corner.